Amfora
Date | Investors | Amount | Round |
---|---|---|---|
$5.0m | Series A | ||
$6.0m | Series B | ||
$1.0m Valuation: $30.0m | Series B | ||
Total Funding | €10.9m |
Recent News about Amfora
EditAmfora is an agricultural company dedicated to human and animal nutrition through innovative biotechnology. Operating in the plant-based protein market, Amfora leverages its patented gene editing technology to develop plant-based replacements for animal proteins and increase the protein content of staple food crops. This approach addresses growing consumer concerns about health and environmental sustainability. Amfora's business model focuses on research and development, partnering with investors who are interested in sustainable agriculture and food security. The company generates revenue through the commercialization of its biotechnology solutions and partnerships with food producers and agricultural firms.
Keywords: gene editing, plant-based protein, biotechnology, sustainable agriculture, food security, human nutrition, animal nutrition, protein enhancement, staple crops, health-conscious consumers.